Vascular responsiveness to protein kinase C activators in mineralocorticoid-hypertensive rats.
This study characterizes vascular reactivity to protein kinase C activators, 12-O-tetradecanoylphorbol-13-acetate (TPA) and mezerein, in normotensive sham and deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Mesenteric arteries were excised, cut helically into strips and placed in a muscle bath for measurement of isometric force generation. Cumulative addition of TPA or mezerein to the bath caused an increase in tension in arteries from hypertensive and normotensive rats. Threshold values for TPA and mezerein (dose that produced a 5 mN/mm2 response) were lower in arteries from DOCA-salt rats (TPA, 0.24 x 10(-8) mol/l; mezerein, 0.32 x 10(-8) mol/l) than in control arteries (TPA, 2.82 x 10(-8) mol/l; mezerein, 2.34 x 10(-8) mol/l). Contractions to TPA in arteries from DOCA hypertensive rats were inhibited by the calcium-channel antagonist verapamil (10(-6) mol/l) to a greater degree than normotensive values. Arteries from rats undergoing DOCA-salt treatment for 5-7 days and from DOCA-treated rats drinking tap water for 4-6 weeks were less responsive to TPA than were arteries from the DOCA-salt hypertensive rats after 4-6 weeks of treatment. Furthermore, responsiveness to TPA in arteries from untreated rats was reduced compared with that in arteries from normotensive rats maintained on high-salt drinking water. Threshold responses to TPA did not differ between arteries incubated with 10(-6) mol/l deoxycorticosterone and those incubated with the vehicle (ethanol). This study demonstrates that arteries from DOCA-salt hypertensive rats are more responsive to the contractile effects of TPA and mezerein than those from normotensive rats.(ABSTRACT TRUNCATED AT 250 WORDS)
Turla
M B
MB
Department of Physiology, University of Michigan, Ann Arbor.
Webb
R C
RC
D000818:Animals; D015220:Calcium Channels / Q000502:physiology; D003900:Desoxycorticosterone; D004224:Diterpenes; D004789:Enzyme Activation / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced / Q000503:physiopathology*; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D011493:Protein Kinase C / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012982:Sodium, Dietary / Q000009:adverse effects; D013729:Terpenes / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D015220:Calcium Channels; D004224:Diterpenes; D012982:Sodium, Dietary; D013729:Terpenes; C011309:mezerein; D003900:Desoxycorticosterone; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate